Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus4971 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A09326 | 31789950 | Eur J Gastroenterol Hepatol | Performance of liver biomarkers, in patients at risk of nonalcoholic steato-hepatitis, according to presence of type-2 diabetes. | 2020 | Details |
A09329 | 31789677 | Curr Opin Lipidol | Fatty liver, cardiometabolic disease and mortality. | 2020 | Details |
A09335 | 31786361 | Diabetes Metab | Screening for non-alcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes. | 2019 | Details |
A09336 | 31786360 | Diabetes Metab | Higher liver stiffness scores are associated with early kidney dysfunction in patients with histologically proven non-cirrhotic NAFLD. | 2019 | Details |
A09345 | 31783635 | Nutrients | Circulating miRNAs as Biomarkers of Obesity and Obesity-Associated Comorbidities in Children and Adolescents: A Systematic Review. | 2019 | Details |
A09349 | 31782258 | Physiol Rep | SGLT2 inhibitor ipragliflozin alone and combined with pioglitazone prevents progression of nonalcoholic steatohepatitis in a type 2 diabetes rodent model. | 2019 | Details |
A09351 | 31782025 | Eur J Clin Microbiol Infect Dis | Nonalcoholic fatty liver disease as a risk factor for Clostridioides difficile infection. | 2019 | Details |
A09354 | 31781248 | Stem Cells Int | Human Umbilical Cord-Derived Mesenchymal Stem Cell Therapy Ameliorates Nonalcoholic Fatty Liver Disease in Obese Type 2 Diabetic Mice. | 2019 | Details |
A09361 | 31777896 | Food Funct | Attenuation of metabolic syndrome in the ob/ob mouse model by resistant starch intervention is dose dependent. | 2019 | Details |
A09375 | 31771244 | Nutrients | Fat and Sugar-A Dangerous Duet. A Comparative Review on Metabolic Remodeling in Rodent Models of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
A09386 | 31766373 | J Clin Med | Pathophysiological Implication of Fetuin-A Glycoprotein in the Development of Metabolic Disorders: A Concise Review. | 2019 | Details |
A09391 | 31763058 | Am J Cardiovasc Dis | Preclinical cardiac disease in nonalcoholic fatty liver disease with and without metabolic syndrome. | 2019 | Details |
A09396 | 31760676 | Intern Med J | Non-alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management. | 2020 | Details |
A09398 | 31760381 | J Basic Clin Physiol Pharmacol | Development of nonalcoholic fatty liver disease model by high-fat diet in rats. | 2019 | Details |
A09399 | 31760308 | J Nutr Biochem | Probiotic culture supernatant improves metabolic function through FGF21-adiponectin pathway in mice. | 2019 | Details |
A09402 | 31759125 | Peptides | The influence of Glucose-dependent Insulinotropic Polypeptide (GIP) on human adipose tissue and fat metabolism: Implications for obesity, type 2 diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD). | 2019 | Details |
A09410 | 31758299 | Rev Endocr Metab Disord | Ghrelin and liver disease. | 2020 | Details |
A09426 | 31754293 | World J Gastroenterol | MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes. | 2019 | Details |
A09427 | 31754157 | Sci Rep | The Impact of NAFLD and Waist Circumference Changes on Diabetes Development in Prediabetes Subjects. | 2019 | Details |
A09428 | 31754142 | Sci Rep | New insight into the mechanisms of ectopic fat deposition improvement after bariatric surgery. | 2019 | Details |
A09437 | 31749914 | Gastroenterol Hepatol Bed Bench | The diagnostic and initial approach of the patient with non-alcoholic fatty liver disease: role of the primary care provider. | 2019 | Details |
A09444 | 31746482 | Aliment Pharmacol Ther | Systematic review: chronic viral hepatitis and metabolic derangement. | 2019 | Details |
A09447 | 31745030 | Indian J Med Microbiol | Gut microbiota and its mysteries. | 2020 | Details |
A09459 | 31737583 | Can J Gastroenterol Hepatol | Association between Smoking and Liver Fibrosis among Patients with Nonalcoholic Fatty Liver Disease. | 2019 | Details |
A09462 | 31734987 | Zhonghua Gan Zang Bing Za Zhi | [Expert recommendations on standardized diagnosis and treatment for fatty liver disease in China (2019 revised edition)]. | 2019 | Details |
A09469 | 31731527 | Nutrients | Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study. | 2019 | Details |
A09544 | 31701070 | Hepatol Commun | Mortality Related to Nonalcoholic Fatty Liver Disease Is Increasing in the United States. | 2019 | Details |
A09548 | 31697972 | J Hepatol | Insulin sensitizer MSDC-0602K in non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled phase IIb study. | 2019 | Details |
A09557 | 31695251 | J Clin Exp Hepatol | Molecular and Pathological Events Involved in the Pathogenesis of Diabetes-Associated Nonalcoholic Fatty Liver Disease. | 2018 | Details |
A09562 | 31694082 | Diabetes Metab J | Severity of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus: Relationship between Nongenetic Factors and PNPLA3/HSD17B13 Polymorphisms. | 2019 | Details |
A09569 | 31692226 | Diabetes Obes Metab | Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetes. | 2019 | Details |
A09573 | 31690988 | Diabetologia | Placebo-controlled randomised trial with liraglutide on magnetic resonance endpoints in individuals with type 2 diabetes: a pre-specified secondary study on ectopic fat accumulation. | 2019 | Details |
A09579 | 31689496 | Diabetes Metab | Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes. | 2019 | Details |
A09585 | 31686320 | Sci China Life Sci | Regulation of glucose and lipid metabolism in health and disease. | 2019 | Details |
A09591 | 31682643 | Frontline Gastroenterol | A multidisciplinary approach to the management of NAFLD is associated with improvement in markers of liver and cardio-metabolic health. | 2019 | Details |
A09594 | 31682518 | Endocr Pract | CLINICAL PRACTICE GUIDELINES FOR THE PERIOPERATIVE NUTRITION, METABOLIC, AND NONSURGICAL SUPPORT OF PATIENTS UNDERGOING BARIATRIC PROCEDURES - 2019 UPDATE: COSPONSORED BY AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY, THE OBESITY SOCIETY, AMERICAN SOCIETY FOR METABOLIC & BARIATRIC SURGERY, OBESITY MEDICINE ASSOCIATION, AND AMERICAN SOCIETY OF ANESTHESIOLOGISTS - EXECUTIVE SUMMARY. | 2019 | Details |
A09612 | 31675274 | Metab Syndr Relat Disord | Relevant Features in Nonalcoholic Steatohepatitis Determined Using Machine Learning for Feature Selection. | 2019 | Details |
A09620 | 31672448 | Metabolism | Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: Think out of the box! | 2019 | Details |
A09624 | 31671589 | Nutrients | Effects of Periodic Fasting on Fatty Liver Index-A Prospective Observational Study. | 2019 | Details |
A09628 | 31669275 | Int J Biol Macromol | Codonopsis lanceolata polysaccharide CLPS alleviates high fat/high sucrose diet-induced insulin resistance via anti-oxidative stress. | 2019 | Details |
A09635 | 31668088 | Int J Environ Health Res | Evaluation of sucrose-enriched diet consumption in the development of risk factors associated to type 2 diabetes, atherosclerosis and non-alcoholic fatty liver disease in a murine model. | 2019 | Details |
A09642 | 31661783 | Metabolites | A Lipidomic Analysis of Docosahexaenoic Acid (22:6, ω3) Mediated Attenuation of Western Diet Induced Nonalcoholic Steatohepatitis in Male Ldlr -/- Mice. | 2019 | Details |
A09648 | 31659239 | Acta Pharmacol Sin | Uncarboxylated osteocalcin ameliorates hepatic glucose and lipid metabolism in KKAy mice via activating insulin signaling pathway. | 2019 | Details |
A09650 | 31658974 | Diabetes Care | Economic and Clinical Burden of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes in the U.S. | 2019 | Details |
A09671 | 31652578 | Int J Mol Sci | The SGLT2 Inhibitor Canagliflozin Prevents Carcinogenesis in a Mouse Model of Diabetes and Non-Alcoholic Steatohepatitis-Related Hepatocarcinogenesis: Association with SGLT2 Expression in Hepatocellular Carcinoma. | 2019 | Details |
A09678 | 31651649 | Eur J Gastroenterol Hepatol | Hepatitis B virus infection and the risk of liver disease progression in type 2 diabetic patients with potential nonalcoholic fatty liver disease: a retrospective, observational, cohort study in the United Kingdom Clinical Practice Research Datalink. | 2020 | Details |
A09687 | 31647808 | PLoS Genet | Causal relationships between obesity and the leading causes of death in women and men. | 2019 | Details |
A09715 | 31635468 | Vnitr Lek | Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
A09722 | 31634046 | J Med Food | Oral Administration of Hoodia parviflora Alleviates Insulin Resistance and Nonalcoholic Steatohepatitis. | 2019 | Details |
A09723 | 31633724 | Arq Gastroenterol | A STUDY OF METABOLIC PARAMETERS IN NON DIABETIC PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE - IMPORTANCE OF DYSLIPIDEMIA. | 2019 | Details |
A09724 | 31633721 | Arq Gastroenterol | EVALUATION OF PROGRESSION OF HEPATIC FIBROSIS IN A GROUP OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANIED FOR 10 YEARS. | 2019 | Details |
A09730 | 31632525 | Am J Transl Res | Neuregulin 4 attenuate tubulointerstitial fibrosis and advanced glycosylation end products accumulation in diabetic nephropathy rats via regulating TNF-R1 signaling. | 2019 | Details |
A09734 | 31632109 | Diabetes Metab Syndr Obes | Plant-derived oleanolic acid ameliorates markers associated with non-alcoholic fatty liver disease in a diet-induced pre-diabetes rat model. | 2019 | Details |
A09736 | 31631098 | Endocr J | Regulation of angiopoietin-like protein 8 expression under different nutritional and metabolic status. | 2019 | Details |
A09738 | 31630897 | Trends Endocrinol Metab | NAFLD and Atherosclerosis: Two Sides of the Same Dysmetabolic Coin? | 2019 | Details |
A09743 | 31629366 | Endocr Rev | Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and Management. | 2020 | Details |
A09759 | 31622202 | Curr Drug Deliv | Protective Effects of Incretin Against Age-Related Diseases. | 2019 | Details |
A09770 | 31616668 | Front Med (Lausanne) | Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis-Literature Review. | 2019 | Details |
A09774 | 31614690 | Int J Mol Sci | Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence. | 2019 | Details |
A09782 | 31612634 | Liver Int | Liver fibrosis by FibroScan® independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes. | 2019 | Details |
A09793 | 31608477 | J Food Biochem | Zingiber officinale extract and omega-3 fatty acids ameliorate endoplasmic reticulum stress in a nonalcoholic fatty liver rat model. | 2019 | Details |
A09798 | 31606352 | Ann Hepatol | Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know? | 2019 | Details |
A09802 | 31604692 | Diabetes Care | Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes. | 2019 | Details |
A09803 | 31604171 | Atherosclerosis | Visceral adipose tissue volume is associated with premature atherosclerosis in early type 2 diabetes mellitus independent of traditional risk factors. | 2019 | Details |
A09812 | 31601203 | BMC Endocr Disord | Prevalence of cardiovascular risk factors in non-menopausal and postmenopausal inpatients with type 2 diabetes mellitus in China. | 2019 | Details |
A09816 | 31599742 | Am J Gastroenterol | The Impact of Obesity and Type 2 Diabetes on Chronic Liver Disease. | 2019 | Details |
A09833 | 31595260 | Porto Biomed J | Prevalence and risk factors of sonographically detected non alcoholic fatty liver disease in a screening centre in Klang Valley, Malaysia: an observational cross-sectional study. | 2018 | Details |
A09860 | 31588816 | Arch Physiol Biochem | The association between retinol-binding protein 4 and prediabetes in obese patients with nonalcoholic fatty liver disease. | 2019 | Details |
A09896 | 31570461 | Anticancer Res | Diabetes Mellitus and/or Nonalcoholic Steatohepatitis-related Hepatocellular Carcinoma Showed Favorable Surgical Outcomes After Hepatectomy. | 2019 | Details |
A09908 | 31565874 | Endocrinol Metab (Seoul) | Nonalcoholic Fatty Liver Disease and Diabetes: An Epidemiological Perspective. | 2019 | Details |
A09915 | 31562711 | J Assoc Physicians India | Association between Non- alcoholic Fatty Liver Disease and Left Ventricular Diastolic Dysfunction in Patients of Type 2 Diabetes. | 2019 | Details |
A09916 | 31562685 | J Hepatobiliary Pancreat Sci | Decrease in major secondary bile acid, hyodeoxycholic acid, was the main alteration in hepatic bile acid compositions in a hypertensive nonalcoholic fatty liver disease model. | 2019 | Details |
A09917 | 31561285 | FEBS Open Bio | Inhibition of sodium-glucose cotransporter 2 ameliorates renal injury in a novel medaka model of nonalcoholic steatohepatitis-related kidney disease. | 2019 | Details |
A09933 | 31554932 | Nat Rev Endocrinol | The regulation of hepatic fatty acid synthesis and partitioning: the effect of nutritional state. | 2019 | Details |
A09940 | 31553600 | J Chem Theory Comput | Molecular Dynamics Study of the Hybridization between RNA and Modified Oligonucleotides. | 2019 | Details |
A09943 | 31551515 | Cell Mol Immunol | NLRP3 inflammasome blockade reduces adipose tissue inflammation and extracellular matrix remodeling. | 2019 | Details |
A09949 | 31547555 | Nutrients | Regulation of Gut Microbiota and Metabolic Endotoxemia with Dietary Factors. | 2019 | Details |
A09958 | 31543468 | Ann Hepatol | Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis. | 2019 | Details |
A09965 | 31543103 | Am J Med Sci | Beware Energy Drinks: A Case of a Toxic Triad Syndrome in a Diabetic Patient With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
A09969 | 31540903 | Diabetes Care | Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial. | 2019 | Details |
A09971 | 31540048 | Int J Environ Res Public Health | NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic Syndrome. | 2019 | Details |
A09978 | 31538291 | Endocrine | Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. | 2019 | Details |
A09980 | 31538216 | Herz | Cardiac abnormalities in patients with nonalcoholic fatty liver disease : Insights from auxiliary examinations. | 2019 | Details |
A09984 | 31536600 | PLoS One | Asprosin response in hypoglycemia is not related to hypoglycemia unawareness but rather to insulin resistance in type 1 diabetes. | 2019 | Details |
A09990 | 31534089 | Intern Med | Predictors of Insulin Secretion in Japanese Patients with Histopathologically-confirmed Non-alcoholic Fatty Liver Disease. | 2019 | Details |
A10000 | 31530739 | Gut Liver | Simple Noninvasive Scores Are Clinically Useful to Exclude, Not Predict, Advanced Fibrosis: A Study in Turkish Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease. | 2020 | Details |
A10013 | 31524533 | Expert Opin Investig Drugs | Multi-drug approaches to NASH: what's in the development pipeline? | 2019 | Details |
A10016 | 31523513 | PeerJ | Association between serum uric acid and nonalcoholic fatty liver disease in community patients with type 2 diabetes mellitus. | 2019 | Details |
A10018 | 31523440 | BMJ Open Gastroenterol | Real-world comorbidities and treatment patterns among patients with non-alcoholic fatty liver disease receiving phosphatidylcholine as adjunctive therapy in Russia. | 2019 | Details |
A10020 | 31522189 | Am J Case Rep | Sugar and the Mosaic of Autoimmunity. | 2019 | Details |
A10027 | 31520549 | Fundam Clin Pharmacol | Tanshinone IIA reduces palmitate-induced apoptosis via inhibition of endoplasmic reticulum stress in HepG2 liver cells. | 2019 | Details |
A10042 | 31516267 | J Clin Exp Hepatol | Screening of Cardiovascular Disease in Nonalcoholic Fatty Liver Disease: Whom and How? | 2019 | Details |
A10048 | 31514105 | Cytokine | Increased plasma osteopontin levels are associated with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. | 2019 | Details |
A10054 | 31510077 | Nutrients | A Low Iron Diet Protects from Steatohepatitis in a Mouse Model. | 2019 | Details |
A10056 | 31506976 | Hepatology | Vitamin D Receptor Activation in Liver Macrophages Ameliorates Hepatic Inflammation, Steatosis, and Insulin Resistance in Mice. | 2020 | Details |
A10066 | 31504822 | Nutr Rev | Role of fruit juice in achieving the 5-a-day recommendation for fruit and vegetable intake. | 2019 | Details |
A10095 | 31488310 | Rev Gastroenterol Mex (Engl Ed) | Extrahepatic complications of non-alcoholic fatty liver disease: Its impact beyond the liver. | 2019 | Details |
A10100 | 31484207 | J Periodontol | Association between periodontal status and non-alcoholic fatty liver disease in a Korean adult population: A nationwide cross-sectional study. | 2019 | Details |
A10103 | 31483669 | J Proteome Res | High Throughput Screening of Serum γ-Glutamyl Dipeptides for Risk Assessment of Nonalcoholic Steatohepatitis with Impaired Glutathione Salvage Pathway. | 2019 | Details |
A10123 | 31474679 | J Nutr Sci Vitaminol (Tokyo) | Association between Vitamin D Status and Non-Alcoholic Fatty Liver Disease: A Population-Based Study. | 2019 | Details |